Mark For: MPBC® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88350382 |
Registration Number | 6121821 |
Mark Literal Elements | MPBC |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-04-20 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Lara Pearson |
2015-02-13 | Date of First Use |
2015-02-13 | Date of Use In Commerce |
2019-03-21 | Application Filed |
2019-04-08 | Location: NEW APPLICATION PROCESSING |
2019-04-08 | Status: Live/Pending |
2019-04-08 | Transaction Date |
2020-04-20 | Location: PUBLICATION AND ISSUE SECTION |
2020-05-26 | Published |
2020-05-26 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
2020-08-11 | Trademark Registered |
Party: | MAPS Public Benefit Corporation |
Address | 1115 Mission Street Santa Cruz, CALIFORNIA UNITED STATES 95060 |
Legal Entity Type | Public Benefit Corporation |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2019-03-21 |
Specimen | JPEG | 2019-03-21 |
TEAS RF New Application | MULTI | 2019-03-21 |
TEAS Rev, App and/or COA of Atty/Dom.Rep | XML | 2019-08-14 |
Offc Action Outgoing | XML | 2020-01-03 |
XSearch Search Summary | XML | 2020-01-03 |
Response to Office Action | MULTI | 2020-03-12 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-03-14 |
TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2020-04-08 |
Notice of Publication | XML | 2020-05-06 |
Notification Of Notice of Publication | XML | 2020-05-06 |
OG Publication Confirmation | APPLICATION/XML | 2020-05-26 |
IC 042. US 100 101. G & S: Psychological research; Medical research; Scientific research; Pharmaceutical research; Research and development of medicines; Research and development of medicinal therapies; Medical and scientific research in the fields of psychotherapy, plant-based medicines, psychedelic therapies and FDA-approved medical marijuana; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of psychedelic research, psychotherapeutic treatments and therapies, MDMA therapies, LSD-assisted psychotherapy, Ibogaine-assisted treatment, Ayahuasca-assisted therapy and FDA-Approved medical marijuana; Conducting scientific feasibility studies; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Research services for medical and pharmaceutical purposes. FIRST USE: 20150213. FIRST USE IN COMMERCE: 20150213
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Psychological research; Medical research; Scientific research; Pharmaceutical research; Research and development of medicines; Research and development of medicinal therapies; Medical and scientific research in the fields of psychotherapy, medical marijuana, plant-based medicines, psychedelic therapies; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of psychedelic research, psychotherapeutic treatments and therapies, MDMA therapies, medical marijuana, LSD-assisted psychotherapy, Ibogaine-assisted treatment, Ayahuasca-assisted therapy; Conducting scientific feasibility studies; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Research services for medical and pharmaceutical purposes |
GS0421 | Psychological research; Medical research; Scientific research; Pharmaceutical research; Research and development of medicines; Research and development of medicinal therapies; Medical and scientific research in the fields of psychotherapy, plant-based medicines, psychedelic therapies and FDA-approved medical marijuana; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of psychedelic research, psychotherapeutic treatments and therapies, MDMA therapies, LSD-assisted psychotherapy, Ibogaine-assisted treatment, Ayahuasca-assisted therapy and FDA-Approved medical marijuana; Conducting scientific feasibility studies; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Research services for medical and pharmaceutical purposes |
Description | Date | Proceeding Number |
---|---|---|
PUBLISHED FOR OPPOSITION | 2020-05-26 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-05-26 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-05-06 | |
ASSIGNED TO LIE | 2020-04-17 | 68171 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-04-07 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-03-13 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-03-12 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-03-12 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-01-03 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-01-03 | 83184 |
NON-FINAL ACTION E-MAILED | 2020-01-03 | 6325 |
ASSIGNED TO EXAMINER | 2020-01-03 | 83184 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-08-14 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-08-14 | |
ASSIGNED TO EXAMINER | 2019-04-15 | 78196 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-04-08 | |
NEW APPLICATION ENTERED IN TRAM | 2019-03-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.